Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-006973
Filing Date
2025-02-14
Accepted
2025-02-14 17:20:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7674
  Complete submission text file 0001493152-25-006973.txt   9374
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Subject) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91570 | Film No.: 25631034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022 212-256-8600
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

EIN.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A